Introduction
Hypoxia-inducible factors (HIF-1alpha and
HIF-2alpha) are closely related protein complexes that activate
transcription of target genes in response to hypoxia.
PMID: 17033215
Abnormal Expression
In tumor cells, low HIF-2alpha expression was
observed in 6.3%, moderate in 31.9% and high in 61.8% of the
cases. A trend of correlation of this expression with MVD was
observed. In addition, HIF-2alpha expression was positively
correlated with thymidine phosphorylase and fibronectin
expression. A lower HIF-2alpha expression was detected in tumors
that recurred earlier in univariate methods of analysis.
HIF-2alpha was expressed in tumor stroma associated cells in
53.5% of specimens and was correlated with advance tumor stage,
thymidine phosphorylase and tenascin expression.
PMID: 17033215
HIF-2alpha is specifically expressed and
appears to be involved in the development of the murine
sympathetic nervous system (SNS). HIF-2alpha was detected in
hypoxic and in well-oxygenized neuroblastoma cells and tissue,
presumably reflecting their embryonic features.
PMID: 15652356
HIF-2alpha/EPAS1 is expressed in most of
hepatocellular carcinoma (HCC) with capsular infiltration and
portal vein invasion, which indicates a possible role of
HIF-2alpha/EPAS1 in HCC metastasis.
PMID: 14966910
Although HIF-2alpha was not detectable under
baseline conditions, marked hypoxic induction occurred in all
organs investigated, including brain, heart, lung, kidney,
liver, pancreas, and intestine. Immunohistochemistry revealed
nuclear accumulation in distinct cell populations of each
tissue, which were exclusively non-parenchymal in some organs
(kidney, pancreas, and brain), predominantly parenchymal in
others (liver and intestine) or equally distributed
(myocardium).
PMID: 12490539
HIF-2alpha/EPAS1 is mostly expressed in
invasive bladder cancer, which indicates a possible role for
HIF-2alpha/EPAS1 in the invasion of bladder cancer.
PMID: 11992927
Overexpression of HIF-1alpha and HIF-2alpha
was demonstrated in three head and neck squamous cell carcinoma
(HNSCC) cell lines under hypoxia and tumor tissue versus normal
tissue (n = 20, HIF-1alpha, P = 0.023; HIF-2alpha, P = 0.013).
On immunostaining, HIF-1alpha and HIF-2alpha expression were
localized to tumor nuclei; HIF-2alpha expression was also seen
in tumor-associated macrophages.
PMID: 11980639
Considering all 48 paired placental biopsy
sites (eight sites each for six normal term and six preeclamptic
placentas), HIF-2alpha protein levels in the preeclamptic
placentas exceeded those in the normal term placentas in 39, or
81%, of the paired sites (P: < 0.0013). The HIF-2alpha
immunoreactivity was mainly located in the nuclei of the
syncytiotrophoblast and fetoplacental vascular endothelium in
the preeclamptic villous placenta. We conclude that protein
expression of HIF-2alpha, but not of HIF-1alpha or -1beta, is
selectively increased in the preeclamptic placenta. The
molecular mechanism(s) of this abnormality as well as the genes
affected downstream are currently under investigation. To our
knowledge, this is the first report of abnormal HIF-2alpha
expression in human disease other than cancer.
PMID: 11159352
In the majority of solid tumors examined,
including bladder, brain, breast, colon, ovarian, pancreatic,
prostate, and renal carcinomas, nuclear expression of HIF-1alpha
and -2alpha was observed in varying subsets of the tumor cells.
HIF-2alpha was also strongly expressed by subsets of
tumor-associated macrophages, sometimes in the absence of any
tumor cell expression. Less frequently staining was observed in
other stromal cells within the tumors and in normal tissue
adjacent to tumor margins. In contrast, in normal tissue neither
molecule was detectable except within subsets of bone marrow
macrophages, where HIF-2alpha was strongly expressed.
PMID: 10934146
Function
additive effect of HIF-2alpha on poor
prognosis suggested that different pathways may be regulated by
HIF-2alph.
PMID: 16826581
HIF-2alpha is not transcriptionally active in
embryonic stem (ES) cells, as well as possible inhibition by a
HIF-2alpha-specific transcriptional repressor.
PMID: 16611993
HIF-2alpha can regulate stem cell function
and/or differentiation through activation of Oct-4, which in
turn contributes to HIF-2alpha's tumor promoting activity.
PMID: 16510872
These data demonstrate an intrinsic
requirement for Hif-2alpha by endothelial cells and imply that
hypoxia may control endothelial functions directly via
Hif-2alpha-regulated Tie-2 expression.
PMID: 15851592
HIF-2alpha may be more important in the
survival response to environmental variables other than the
level of oxygen.
PMID: 11546756
Applications
Immunohistochemistry (IHC)
Expression of HIF-2alpha/EPAS1 was
investigated immunohistochemically on paraffin-embedded sections
from 97 patients with hepatocellular carcinoma (HCC).
PMID: 14966910
Expression of HIF-2alpha/EPAS1 protein was
also investigated immunohistochemically on paraffin-embedded
sections from 24 patients with bladder cancer.
PMID: 11992927
our aim was to investigate the distribution
of HIF-1alpha and HIF-2alpha by immunohistochemistry in normal
and pathological tissues using monoclonal antibodies (mAb).
PMID: 10934146
Western Blot (WB)
Two bladder cancer cell lines (T24, EJ-1)
were examined for the expression of HIF-2alpha/EPAS1 mRNA by
reverse transcriptase-polymerase chain reaction and
HIF-2alpha/EPAS1 protein by Western blot analysis, respectively.
PMID: 11992927